Specifically, different Vδ2+ cell phenotypes post-expansion preferentially produced either granzyme B or granzyme K in responses to tumour cell lines, differentially affecting their ability to lyse a range of tumour cell lines. The gene discussed is GZMB; the disease is neoplasm.